[{"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078378"], "brand_name": ["REVONTO"], "generic_name": ["DANTROLENE SODIUM"], "manufacturer_name": ["USWM, LLC"], "product_ndc": ["78670-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DANTROLENE SODIUM"], "rxcui": ["856696", "1012465"], "spl_id": ["e2a8cdae-f253-4b7a-b9ab-c66506106aef"], "spl_set_id": ["f1650487-32bd-4017-b9c2-b38829a531af"], "package_ndc": ["78670-003-67"], "is_original_packager": [true], "unii": ["287M0347EV"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1081-2022", "product_description": "Revonto (dantrolene sodium for injection), 20 mg/vial, 6-count box, Rx only, MFG: US WorldMeds, Inc.,  NDC 78670-003-67", "product_quantity": "49 cartons/6 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90127", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to FL, SC and VA", "recall_number": "D-0886-2022", "product_description": "Losartan HCTZ 100/25 mg, 90 count bottles  NDC# 70518-2578-00 Repackaged NDC  Original NDC # 68180-0217-09", "product_quantity": "26/90 count bottles = 2,340 tablets", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.", "recall_initiation_date": "20220502", "center_classification_date": "20220520", "termination_date": "20220902", "report_date": "20220601", "code_info": "Lot #   B1329507-082921, exp. date 08/31/2022  B1348363-091421, exp. date 09/30/2022  B1387286-101021, exp. date 10/31/2022  B1390974-101221, exp. date 10/31/2022  B1426010-110521, exp. date 11/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0802-2022", "product_description": "AT-1, Papaverine 8mg/ml . Phentolamine 2mg/ml . Atropine 0.2mg/ml, Multi-Dose 10 ml vial,  Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0039-10", "product_quantity": "310 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: F41C28 BUD: 6/28/2022, F41B28 BUD: 6/28/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1138-2022", "product_description": "Syphilinum, Potency: 9C, 30C, 200C, 10X, 12X, Liquid Pellets, Rx only,  Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "15 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot# 20390, 20441, 20389", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0953-2022", "product_description": "Epinephrine Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Pre-Filled Syringe, 5 x 10 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-925-10", "product_quantity": "134415 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lots: EN1047A, Exp. 6/7/2022; EN2002A, Exp. 7/7/2022; EN2006A, Exp. 7/19/2022; EN2011A, Exp. 9/1/2022"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1079-2022", "product_description": "Vecuronium Bromide for Injection, 10 mg (1mg/ mL) vial, 10-count box, Rx only, MFG: Teva Pharma USA, NDC 0703-2914-03", "product_quantity": "20 cartons/10 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90080", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0829-2022", "product_description": "Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-078-40", "product_quantity": "120 bags", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220425", "center_classification_date": "20220502", "termination_date": "20220909", "report_date": "20220511", "code_info": "Lot #: 1222035815, Exp. Date 10-Jul-22"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["PHENOBARBITAL SODIUM"], "generic_name": ["PHENOBARBITAL SODIUM"], "manufacturer_name": ["Cameron Pharmaceuticals"], "product_ndc": ["42494-415", "42494-416"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PHENOBARBITAL SODIUM"], "rxcui": ["2671204", "2671207"], "spl_id": ["f69a86e8-b217-47eb-b536-2b5677cfe85f"], "spl_set_id": ["50e73787-ede1-4839-aaa5-806e25f18b1a"], "package_ndc": ["42494-416-25", "42494-416-03", "42494-415-25", "42494-415-03"], "is_original_packager": [true], "unii": ["SW9M9BB5K3"]}, "product_type": "Drugs", "event_id": "89803", "recalling_firm": "Vitae Enim Vitae Scientific, Inc.", "address_1": "3030 Bunker Hill St Ste 203", "address_2": "", "postal_code": "92109-5754", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0743-2022", "product_description": "PHENOBARBITAL Sodium Injection, USP, 65mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-415-25) and b) 3 x 1 mL Vials per box (NDC 42494-415-03), Rx only, Manufactured for Cameron Pharmaceuticals, LLC.", "product_quantity": "a) 21,501 boxes; b) 4,846 boxes", "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20220314", "center_classification_date": "20220405", "termination_date": "20240815", "report_date": "20220413", "code_info": "Lot #: a) 20VPSI007, Exp 3/31/2022; 20VPSI015, Exp 5/30/2022; 20VPSI018, Exp 6/1/2022; 20VPSI032, Exp 11/30/2022; 21VPSI002, 21VPSI003, Exp 1/31/2023; 21VPSI006, Exp 3/31/2023; 21VPSI012, 21VPSI020, Exp 5/31/2023; 21VPSI035, Exp 7/31/2023; 21VPSI037, 21VPSI038, Exp 8/31/2023; 21VPSI043, 21VPSI044, Exp 10/31/2023; 21VPSI050, 21VPSI051, Exp 11/30/2023; 22VPSI004, Exp 7/31/2024; 22VPSI006, Exp 8/31/2024; b) 20VPSI008, Exp 3/31/2022; 20VPSI019, Exp 6/30/2022; 21VPSI050, Exp 11/30/2023,", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0965-2022", "product_description": "Phenylephrine HCl Injection, USP, 0.4 mg/10 mL (40 mcg/mL), 10 mL Pre-Filled Syringe, 5 x 10 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-955-10", "product_quantity": "57810 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lots: PE1108A, Exp. 5/27/2022; PE2006A, Exp. 8/3/2022; PE2010A, Exp. 8/12/2022"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0906-2022", "product_description": "Sodium Tetradecyl Sulfate 0.3% Injection, Multi-Dose 30 mL vial,  Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0121-30", "product_quantity": "943 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: B24309-22 BUD: 8/9/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018634"], "brand_name": ["BETADINE"], "generic_name": ["POVIDONE-IODINE"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-0411"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["312570", "1149663"], "spl_id": ["45bf2066-cfd2-48ef-acf9-b590c69b83d8"], "spl_set_id": ["b026de1b-9949-4557-ac49-c7b0038c24cd"], "package_ndc": ["0065-0411-30"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1008-2022", "product_description": "Betadine 5%, Sterile Ophthalmic Prep Solution, (povidine-iodine ophthalmic solution), 1 fl. oz. (30 mL), Rx only, Mfd for: Alcon Surgical Inc., NDC 0065-0411-30", "product_quantity": "799 cartons/1 bottle each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0903-2022", "product_description": "Diluent for Reconstitution Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0113-10", "product_quantity": "42,722 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: J24125, J24025 BUD: 10/25/2022; K24002 BUD: 11/2/2022; L24013, L24213 BUD: 12/13/2022; A24003 BUD: 1/3/2023; A24404 BUD: 1/4/2023; A24031-22 BUD: 1/31/2023; B24001-22 BUD: 2/1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1064-2022", "product_description": "MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL), 5 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-473-01", "product_quantity": "", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1089-2022", "product_description": "Celestone Soluspan (betamethasone sodium phosphate and betametasone acetate injectable suspension 6 mg/mL, 30 mg/5mL, multidose vial, Rx only, MFG: Merck Company, NDC 0085-4320-01", "product_quantity": "51 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1029-2022", "product_description": "Ciprofloxacin Ophthalmic Solution 0.3%, 10 mL bottle, Rx only, Manufactured by: Alcon Laboratories, Inc., NDC 61314-0656-10", "product_quantity": "1 bottle", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA064076"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-2020", "0781-2613", "0781-5060", "0781-5061", "0781-6039", "0781-6156", "0781-6041", "0781-6157"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308182", "308189", "308191", "308192", "308194", "313797", "313850"], "spl_id": ["6aa02079-d11c-4d2f-acaf-9548dd9a7ed6"], "spl_set_id": ["13bd4214-9b7f-425b-af5f-fc1ddc678230"], "package_ndc": ["0781-2020-31", "0781-2020-76", "0781-2020-01", "0781-2020-05", "0781-2613-31", "0781-2613-76", "0781-2613-01", "0781-2613-05", "0781-5060-20", "0781-5060-01", "0781-5061-20", "0781-5061-01", "0781-6039-58", "0781-6039-46", "0781-6039-55", "0781-6156-52", "0781-6156-57", "0781-6156-46", "0781-6041-58", "0781-6041-46", "0781-6041-55", "0781-6157-52", "0781-6157-57", "0781-6157-46"], "is_original_packager": [true], "upc": ["0307816156526", "0307812020012", "0307816041587", "0307815060015", "0307815061012", "0307816157523", "0307816039584", "0307812613016"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1025-2022", "product_description": "Amoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only,  MFG: Sandoz Pharma, NDC 0781-2613-01", "product_quantity": "12 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0795-2022", "product_description": "NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.  NDC 73198-0083-00", "product_quantity": "16,329 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E24026 BUD: 5/26/2022, E42112 BUD: 5/12/2022, E48024 BUD: 2/2/2022, F24014 BUD: 6/14/2022,  G48028 BUD: 7/28/2022, H24016 BUD: 8/16/2022, H42010 BUD 8/10/2022, H48030 BUD: 8/11/2022, I47003 BUD: 8/11/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078295"], "brand_name": ["SUMATRIPTAN SUCCINATE"], "generic_name": ["SUMATRIPTAN SUCCINATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-520", "62756-521", "62756-522"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUMATRIPTAN SUCCINATE"], "spl_id": ["9035f04f-b353-4883-9ac2-e030f18bfc1c"], "spl_set_id": ["9485cc30-15e8-4b53-876d-db317145474b"], "package_ndc": ["62756-520-83", "62756-520-88", "62756-520-08", "62756-520-18", "62756-520-69", "62756-520-93", "62756-520-01", "62756-521-83", "62756-521-88", "62756-521-08", "62756-521-18", "62756-521-69", "62756-521-93", "62756-521-01", "62756-522-83", "62756-522-88", "62756-522-08", "62756-522-18", "62756-522-69", "62756-522-93", "62756-522-01"], "is_original_packager": [true], "upc": ["0362756521889", "0362756522886"], "unii": ["J8BDZ68989"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1111-2022", "product_description": "Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69", "product_quantity": "1 carton/9 blister packs", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019885"], "brand_name": ["ACCUPRIL"], "generic_name": ["QUINAPRIL HYDROCHLORIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-0527", "0071-0530", "0071-0532", "0071-0535", "0071-1205", "0071-1410", "0071-1620", "0071-1840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["207891", "207892", "207893", "207895", "312748", "312749", "312750", "314203"], "spl_id": ["ee20d3b1-a5c8-4510-a931-3872df7b77f4"], "spl_set_id": ["63cf5651-d52c-4d27-9fd4-ed9cd9724dff"], "package_ndc": ["0071-0527-23", "0071-0530-23", "0071-0530-40", "0071-0532-23", "0071-0532-40", "0071-0535-23", "0071-1205-23", "0071-1410-23", "0071-1620-23", "0071-1840-23"], "is_original_packager": [true], "upc": ["0300710527232", "0300710532236", "0300711620239", "0300711410236", "0300711840231", "0300710535237", "0300710530232", "0300711205238"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "90064", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0872-2022", "product_description": "Accupril (Quinapril HCl Tablets) 10 mg,  90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017", "product_quantity": "2079 bottles", "reason_for_recall": "CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.", "recall_initiation_date": "20220422", "center_classification_date": "20220516", "termination_date": "20231005", "report_date": "20220525", "code_info": "Lot: DR9639 Exp. MAR 31 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90415", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.", "recall_number": "D-1150-2022", "product_description": "Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16", "product_quantity": "3,216 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.", "recall_initiation_date": "20220610", "center_classification_date": "20220615", "termination_date": "20230208", "report_date": "20220622", "code_info": "Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0945-2022", "product_description": "Phenylephrine 1 mg/mL, Multi-Dose 5 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0021-05.", "product_quantity": "9102 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: K41016 BUD: 11/16/2022 and A24025-22 BUD: 1/25/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203294"], "brand_name": ["AZITHROMYCIN"], "generic_name": ["AZITHROMYCIN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-174"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AZITHROMYCIN MONOHYDRATE"], "rxcui": ["1668238"], "spl_id": ["6760771b-9c61-458d-9778-81a3da96cb9f"], "spl_set_id": ["7b81436e-d14a-4353-a22d-253f45e2e576"], "package_ndc": ["55150-174-10"], "is_original_packager": [true], "unii": ["JTE4MNN1MD"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0997-2022", "product_description": "Azithromycin for Injection USP Vial, 500 mg per vial, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-174-10", "product_quantity": "13 carton/10 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89876", "recalling_firm": "Teva Pharmaceuticals USA Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0765-2022", "product_description": "IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North Wales, PA 19454, NDC 0703-4154-11.", "product_quantity": "1565 vials", "reason_for_recall": "Presence of Particulate Matter: Product was found to contain silica and iron oxide", "recall_initiation_date": "20220329", "center_classification_date": "20220411", "termination_date": "20230620", "report_date": "20220420", "code_info": "Lot #: 31329657B, Exp. Date 08/2023"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89950", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA and CA.", "recall_number": "D-0769-2022", "product_description": "Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for Prevacid, 90-Count Bottle, Manufacturer: Dr Reddy's Laboratories Limited, NDC 68788-6390-09", "product_quantity": "791 bottles of 90 - Count", "reason_for_recall": "Out of specification results observed in dissolution during long term stability testing.", "recall_initiation_date": "20220328", "center_classification_date": "20220414", "termination_date": "20220510", "report_date": "20220420", "code_info": "Lots: H0221R, D3021T, D2221J, D1321X, Exp.12/31/2023."}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1074-2022", "product_description": "MethyLPREDNISolone Acetate Injectable Suspension USP, 400 mg/5mL (80 mg/mL), 5 mL multi-dose vials, Rx only, MFG: Teva Pharma USA, NDC 0703-0063-01", "product_quantity": "816 cartons/1 vial each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA040659"], "brand_name": ["MECLIZINE HYDROCHLORIDE"], "generic_name": ["MECLIZINE HYDROCLORIDE"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-121", "59746-122"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MECLIZINE HYDROCHLORIDE"], "rxcui": ["995624", "995666"], "spl_id": ["ead33f00-e158-464f-953f-ab5a9a391199"], "spl_set_id": ["9350fefc-9c00-182c-c3a9-044d4a40856f"], "package_ndc": ["59746-122-06", "59746-122-10", "59746-121-06", "59746-121-10"], "is_original_packager": [true], "upc": ["0359746121068", "0359746122065"], "unii": ["HDP7W44CIO"]}, "product_type": "Drugs", "event_id": "89854", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.", "recall_number": "D-0767-2022", "product_description": "Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06", "product_quantity": "12,174 bottles", "reason_for_recall": "Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride", "recall_initiation_date": "20220308", "center_classification_date": "20220412", "termination_date": "20221115", "report_date": "20220406", "code_info": "Lot # 22P0036, Exp 12/2024"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0800-2022", "product_description": "Formula F9, Papaverine 0.9mg/ml . Phentolamine 0.1mg/ml . PGE 20mcg/mL Atropine 0.01mg/ml, Multi-Dose 10 ml vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC: 73198-0004-10", "product_quantity": "800 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: D41C19 BUD: 4/19/2022, I42C13 BUD: 9/13/2022, I42B13 BUD: 9/13/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA011245"], "brand_name": ["GASTROGRAFIN"], "generic_name": ["DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM"], "manufacturer_name": ["Bracco Diagnostics Inc"], "product_ndc": ["0270-0445"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RECTAL"], "substance_name": ["DIATRIZOATE MEGLUMINE", "DIATRIZOATE SODIUM"], "spl_id": ["7c17ff73-033f-4c13-b31d-3f84a9f88768"], "spl_set_id": ["8c2340e4-2b42-45dc-8fac-9960e8172547"], "package_ndc": ["0270-0445-35", "0270-0445-40"], "is_original_packager": [true], "upc": ["0302700445403"], "unii": ["3X9MR4N98U", "V5403H8VG7"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1086-2022", "product_description": "Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP), packaged in: Twenty-four 30 mL single dose bottles, Rx only, MFG: Bracco Diagnostics Inc., NDC 0270-0445-35", "product_quantity": "1 case", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205050"], "brand_name": ["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"], "generic_name": ["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-9651"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TRAVOPROST"], "rxcui": ["284008"], "spl_id": ["7a6a2083-70a0-4089-88f0-9ddc088376ce"], "spl_set_id": ["00dc284f-fd96-423b-bb8f-b90ee13439bf"], "package_ndc": ["0378-9651-32", "0378-9651-50"], "is_original_packager": [true], "upc": ["0303789651327"], "nui": ["N0000175454", "M0017805"], "pharm_class_epc": ["Prostaglandin Analog [EPC]"], "pharm_class_cs": ["Prostaglandins [CS]"], "unii": ["WJ68R08KX9"]}, "product_type": "Drugs", "event_id": "89906", "recalling_firm": "Mylan Pharmaceuticals Inc", "address_1": "3711 Collins Ferry Rd", "address_2": "", "postal_code": "26505-2362", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0748-2022", "product_description": "Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.", "product_quantity": "20,112 bottles", "reason_for_recall": "Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.", "recall_initiation_date": "20220401", "center_classification_date": "20220406", "termination_date": "20230227", "report_date": "20220413", "code_info": "Lot # TV11W101, Exp Mar 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89930", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "N/A", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA", "recall_number": "D-0860-2022", "product_description": "Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10 cards of 6 Capsules each per carton), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC 42292-009-16", "product_quantity": "555 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.", "recall_initiation_date": "20220401", "center_classification_date": "20220511", "termination_date": "20230609", "report_date": "20220518", "code_info": "Lot #: 3112743, Exp. Date 4/30/2023; 3112582, Exp. Date 3/31/2023; 3110438, 3111708, 3111120, Exp. Date 7/31/2022"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020125"], "brand_name": ["ACCURETIC"], "generic_name": ["QUINAPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-3112", "0071-0223", "0071-5212", "0071-7225"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "QUINAPRIL HYDROCHLORIDE"], "rxcui": ["310796", "310797", "310809", "809854", "809858", "882559"], "spl_id": ["489727cb-429e-4f04-a973-ae4dc7898519"], "spl_set_id": ["80e9d61d-9674-4ac4-b84c-79a875d408dd"], "package_ndc": ["0071-0223-23", "0071-3112-23", "0071-5212-23", "0071-7225-23"], "is_original_packager": [true], "upc": ["0300717225230", "0300713112237", "0300710223233", "0300715212232"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "33067B3N2M"]}, "product_type": "Drugs", "event_id": "89864", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0761-2022", "product_description": "Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20 mg/12.5 mg*, 90 Tablets, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY. NY 10017, Made in Germany,  NDC 0071-5212-23    .", "product_quantity": "195 bottles", "reason_for_recall": "CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.", "recall_initiation_date": "20220321", "center_classification_date": "20220406", "termination_date": "20240828", "report_date": "20220413", "code_info": "Lot FG5381; Exp. 08/2024", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0963-2022", "product_description": "Neostigmine Methylsulfate Injection, USP, 5 mg/5 mL (1 mg/mL), Preservative Free, 5 mL Pre-Filled Syringe, 5 x 5 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-902-05", "product_quantity": "64450 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lots: NE2001A, Exp. 6/30/2022; NE2009B, Exp. 8/27/2022"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019885"], "brand_name": ["ACCUPRIL"], "generic_name": ["QUINAPRIL HYDROCHLORIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-0527", "0071-0530", "0071-0532", "0071-0535", "0071-1205", "0071-1410", "0071-1620", "0071-1840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["207891", "207892", "207893", "207895", "312748", "312749", "312750", "314203"], "spl_id": ["ee20d3b1-a5c8-4510-a931-3872df7b77f4"], "spl_set_id": ["63cf5651-d52c-4d27-9fd4-ed9cd9724dff"], "package_ndc": ["0071-0527-23", "0071-0530-23", "0071-0530-40", "0071-0532-23", "0071-0532-40", "0071-0535-23", "0071-1205-23", "0071-1410-23", "0071-1620-23", "0071-1840-23"], "is_original_packager": [true], "upc": ["0300710527232", "0300710532236", "0300711620239", "0300711410236", "0300711840231", "0300710535237", "0300710530232", "0300711205238"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "90064", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0873-2022", "product_description": "Accupril (Quinapril HCl Tablets) 20 mg,  90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017", "product_quantity": "10,304 bottles", "reason_for_recall": "CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.", "recall_initiation_date": "20220422", "center_classification_date": "20220516", "termination_date": "20231005", "report_date": "20220525", "code_info": "Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["PHENOBARBITAL SODIUM"], "generic_name": ["PHENOBARBITAL SODIUM"], "manufacturer_name": ["Cameron Pharmaceuticals"], "product_ndc": ["42494-415", "42494-416"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["PHENOBARBITAL SODIUM"], "rxcui": ["2671204", "2671207"], "spl_id": ["f69a86e8-b217-47eb-b536-2b5677cfe85f"], "spl_set_id": ["50e73787-ede1-4839-aaa5-806e25f18b1a"], "package_ndc": ["42494-416-25", "42494-416-03", "42494-415-25", "42494-415-03"], "is_original_packager": [true], "unii": ["SW9M9BB5K3"]}, "product_type": "Drugs", "event_id": "89803", "recalling_firm": "Vitae Enim Vitae Scientific, Inc.", "address_1": "3030 Bunker Hill St Ste 203", "address_2": "", "postal_code": "92109-5754", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the U.S.A", "recall_number": "D-0744-2022", "product_description": "PHENOBARBITAL Sodium Injection, USP, 130 mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-416-25) and b) 3 x 1mL Vials per box (NDC 42494-416-03), Rx only, Manufactured for Cameron Pharmaceuticals, LLC.", "product_quantity": "a) 18,531 boxes; b) 4,492 boxes", "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20220314", "center_classification_date": "20220405", "termination_date": "20240815", "report_date": "20220413", "code_info": "Lot # a) 20VPSI011, Exp. 4/30/2022; 20VPSI014, Exp. 5/31/2022; 20VPSI020, 20VPSI022, 20VPSI023, Exp. 7/31/2022; 21VPSI007, Exp. 3/31/2023; 21VPSI013, Exp. 5/31/2023; 21VPSI027, Exp. 6/30/2023; 21VPSI039, Exp. 8/31/2023; 21VPSI042, Exp. 10/31/2023; 21VPSI049, Exp. 11/30/2023; 21VPSI052, Exp. 12/31/2023; 22VPSI005, Exp. 7/31/2024; 22VPSI007, Exp. 8/31/2024; Lots: b) 22VPSI007, Exp. 8/31/2024; 20VPSI009, Exp. 3/31/2022; 20VPSI020, Exp. 7/31/2022; 21VPSI039, Exp. 8/31/2023; 22VPSI005, Exp. 7/31/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1107-2022", "product_description": "Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP, sterile, 0.1%, 10 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131462810", "product_quantity": "44 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0728-2022", "product_description": "GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS Pharmacy", "product_quantity": "6017 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lots: 745708 BUD: 6/21/2022; 753364 BUD: 7/27/2022; 752508 BUD: 7/24/2022; 750313 BUD: 7/16/2022; 753020 BUD: 7/26/2022; 747712 BUD: 7/4/2022; 747974 BUD: 7/5/2022; 754802 BUD: 8/3/2022; 751158 BUD: 7/19/2022; 756837 BUD: 8/16/2022; 748939 BUD: 7/10/2022; 750842 BUD: 7/18/2022; 755742 BUD: 8/8/2022; 758691 BUD: 8/28/2022; 758432 BUD: 8/27/2022; 758975 BUD: 8/29/2022; 756643 BUD: 8/15/2022"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019885"], "brand_name": ["ACCUPRIL"], "generic_name": ["QUINAPRIL HYDROCHLORIDE"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "product_ndc": ["0071-0527", "0071-0530", "0071-0532", "0071-0535", "0071-1205", "0071-1410", "0071-1620", "0071-1840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["QUINAPRIL HYDROCHLORIDE"], "rxcui": ["207891", "207892", "207893", "207895", "312748", "312749", "312750", "314203"], "spl_id": ["ee20d3b1-a5c8-4510-a931-3872df7b77f4"], "spl_set_id": ["63cf5651-d52c-4d27-9fd4-ed9cd9724dff"], "package_ndc": ["0071-0527-23", "0071-0530-23", "0071-0530-40", "0071-0532-23", "0071-0532-40", "0071-0535-23", "0071-1205-23", "0071-1410-23", "0071-1620-23", "0071-1840-23"], "is_original_packager": [true], "upc": ["0300710527232", "0300710532236", "0300711620239", "0300711410236", "0300711840231", "0300710535237", "0300710530232", "0300711205238"], "unii": ["33067B3N2M"]}, "product_type": "Drugs", "event_id": "90064", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0874-2022", "product_description": "Accupril (Quinapril HCl Tablets) 40 mg,  90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017", "product_quantity": "8346 bottles", "reason_for_recall": "CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.", "recall_initiation_date": "20220422", "center_classification_date": "20220516", "termination_date": "20231005", "report_date": "20220525", "code_info": "Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078232"], "brand_name": ["LOSARTAN POTASSIUM"], "generic_name": ["LOSARTAN POTASSIUM"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-210", "68180-211", "68180-212", "68180-376", "68180-377", "68180-378", "68180-307", "68180-308", "68180-309"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOSARTAN POTASSIUM"], "rxcui": ["979480", "979485", "979492"], "spl_id": ["27867fce-5ba2-4df2-8d82-7ec145cc6197"], "spl_set_id": ["e5886220-43b7-46e1-9034-5242ba245bd1"], "package_ndc": ["68180-210-09", "68180-210-03", "68180-210-01", "68180-210-06", "68180-211-06", "68180-211-09", "68180-211-03", "68180-211-01", "68180-212-06", "68180-212-03", "68180-212-09", "68180-212-01", "68180-376-03", "68180-376-06", "68180-376-01", "68180-376-09", "68180-377-03", "68180-377-01", "68180-377-09", "68180-377-06", "68180-378-09", "68180-378-03", "68180-378-06", "68180-378-01", "68180-307-01", "68180-307-02", "68180-307-09", "68180-307-06", "68180-308-06", "68180-308-09", "68180-308-02", "68180-308-01", "68180-309-06", "68180-309-09", "68180-309-02", "68180-309-01"], "is_original_packager": [true], "upc": ["0368180308027", "0368180376095", "0368180211068", "0368180376033", "0368180378037", "0368180210061", "0368180377030", "0368180309024", "0368180212065"], "unii": ["3ST302B24A"]}, "product_type": "Drugs", "event_id": "89916", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide", "recall_number": "D-0839-2022", "product_description": "Losartan Potassium Tablets USP, 50 mg, a) 90-count bottles (NDC# 68180-377-03), b) 1000-count bottles (NDC#  68180-377-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA.", "product_quantity": "1,466,150 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220331", "center_classification_date": "20220503", "termination_date": "20230522", "report_date": "20220511", "code_info": "H903720, exp. date Oct-22  H001876, exp. date Dec-22  H003002, exp. date Jan-23  H903774, exp. date Oct-22  H001877, exp. date Dec-22  H003003, exp. date Feb-23  H000849, exp. date Nov-22  H002127, exp. date Dec-22  H003004, exp. date Feb-23  H001412, exp. date Nov-22  H002128, exp. date Dec-22  H003123, exp. date Feb-23  H001413, exp. date Nov-22  H002643, exp. date Jan-23  H003124, exp. date Feb-23  H001414, exp. date Nov-22  H002644, exp. date Jan-23  H101129, exp. date Feb-23  H001430, exp. date Nov-22  H002645, exp. date Jan-23  H101147, exp. date Mar-23  H001526, exp. date Dec-22  H002839, exp. date Jan-23  H102139, exp. date Mar-23  H001652, exp. date Dec-22  H002840, exp. date Jan-23  H102158, exp. date Mar-23  H000605, exp. date Jan-23  H001599, exp. date Dec-22  H100148, exp. date Feb-23  H001401, exp. date Nov-22  H001875, exp. date Dec-22  H102043, exp. date Mar-23  H001063, exp. date Nov-22  H002126, exp. date Dec-22  H101495, exp. date Mar-23  H001188, exp. date Nov-22  H002838, exp. date Jan-23   H001455, exp. date Nov-22  H002642, exp. date Jan-23"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202289"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-050", "33342-051", "33342-052"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["cf31d31e-9355-47da-9c2b-8e4b84ac8159"], "spl_set_id": ["a04b5622-2c49-4d61-92b1-5dc523af7a24"], "package_ndc": ["33342-050-07", "33342-050-10", "33342-050-44", "33342-050-12", "33342-051-07", "33342-051-10", "33342-051-44", "33342-051-12", "33342-052-07", "33342-052-10", "33342-052-44", "33342-052-12"], "is_original_packager": [true], "upc": ["0333342051448", "0333342050106", "0333342052100", "0333342051103", "0333342052445", "0333342051073", "0333342052070"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "90037", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0835-2022", "product_description": "Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-count bottles (NDC# 33342-050-07), b) 90-count bottles (NDC # 33342-050-10)  c) 1000-count bottles (NDC # 33342-050-44), Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220415", "center_classification_date": "20220503", "termination_date": "20231013", "report_date": "20220511", "code_info": "Lot #   BLK2107B, exp. date 05/2023  BLK2101A, exp. date 01/2025  BLK2102A, exp. date 02/2025  BLK2103B, exp. date 02/2023  BLK2103C, exp. date 02/2023  BLK2104A, exp. date 05/2023"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0915-2022", "product_description": "Vitamin D3 (50,000 IU/mL)Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0075-30", "product_quantity": "3083 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: L24009 BUD: 6/9/2022; L24028 BUD: 6/28/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89993", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-0846-2022", "product_description": "Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04", "product_quantity": "66,744 bottles", "reason_for_recall": "Failed viscosity specification - product was below specificcation", "recall_initiation_date": "20220415", "center_classification_date": "20220505", "termination_date": "20230928", "report_date": "20220511", "code_info": "Lot #: 370978, Exp 9/30/2022"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0798-2022", "product_description": "QM-2 Papaverine 30 mg/mL. Phentolamine 3 mg/mL . Alprostadil 60 mcg/mL . Atropine 0.2 mg/mL, Multi-Dose 10 mL vial, Rx Only Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC: 73198-0018-10.", "product_quantity": "1871 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: D41219 BUD: 4/19/2022, I24C13 BUD: 9/13/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201720"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-015", "62756-017", "62756-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["bf24bb84-d12f-44e7-98bd-46f3aa792bcc"], "spl_set_id": ["3653a602-4551-4e6c-84a7-31861f5dc482"], "package_ndc": ["62756-017-40", "62756-015-40", "62756-016-40"], "is_original_packager": [true], "upc": ["0362756017405", "0362756015401", "0362756016408"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "90361", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-1153-2022", "product_description": "Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.", "product_quantity": "97,450 vials", "reason_for_recall": "CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.", "recall_initiation_date": "20220603", "center_classification_date": "20220621", "termination_date": "20230524", "report_date": "20220629", "code_info": "HAC1974A, HAC1978A, Exp 06/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Smyrna", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M003"], "brand_name": ["ISOPROPYL ALCOHOL"], "generic_name": ["ISOPROPYL ALCOHOL"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-798"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ISOPROPYL ALCOHOL"], "rxcui": ["808520"], "spl_id": ["4110e082-dda7-4d4e-e063-6394a90a659c"], "spl_set_id": ["d980969d-694b-4c9e-a931-73beaceb51da"], "package_ndc": ["53329-798-03", "53329-798-04", "53329-798-23", "53329-798-25", "1088827736"], "is_original_packager": [true], "unii": ["ND2M416302"]}, "product_type": "Drugs", "event_id": "90453", "recalling_firm": "Vi-Jon, LLC", "address_1": "1 Swan Dr", "address_2": "", "postal_code": "37167-2099", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1151-2022", "product_description": "70% ISOPROPYL ALCOHOL First aid antiseptic, 4 FL OZ (118 mL) bottle, Made in US with US and foreign components for Medline Industries, Inc., Mundelein, IL 60060 USA, NDC: 53329-798-04, UPC (01) 10888277362291.", "product_quantity": "3,157,620 bottles", "reason_for_recall": "Defective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient tightening.", "recall_initiation_date": "20220615", "center_classification_date": "20220621", "termination_date": "20240705", "report_date": "20220629", "code_info": "Lots #s: 0517418, Exp. 12/2022; 0506632, 0519195, 0522494, Exp. 01/2023; 0525627, 0525629, 0526051, 0526052, 0527664, 0527665, Exp. 03/2023; 0531133, 0531134, Exp. 04/2023; 0533153, 0534050, Exp. 05/2023; 0534585, 0534587, 0536089, Exp. 06/2023; 0538694, 0541334, Exp. 07/2023; 0539877, 0542355, Exp. 08/2023; 0545225, 0547054, 0547055, 0547131, Exp. 09/2023; 0547130, 0551014, 0551015, 0552608, Exp. 10/2023; 0552609, 0552610, 0553905, Exp. 11/2023; 0556144, 0557513, Exp. 12/2023; 0559594, 0559602, 0559603, Exp. 01/2024; 0551013, 0559596, 0559604, 0559605, 0561393, 0561395, Exp. 02/2024; 0556143, 0561396, 0561549, Exp. 03/2024; 0565877, Exp. 04/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020742"], "brand_name": ["BSS"], "generic_name": ["BALANCED SALT SOLUTION"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-0795"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CALCIUM CHLORIDE", "MAGNESIUM CHLORIDE", "POTASSIUM CHLORIDE", "SODIUM ACETATE", "SODIUM CHLORIDE", "SODIUM CITRATE"], "rxcui": ["806392", "806396"], "spl_id": ["f56f90e2-cd68-445b-b8fb-74a53f0f2ca6"], "spl_set_id": ["4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea"], "package_ndc": ["0065-0795-15", "0065-0795-30", "0065-0795-25", "0065-0795-50"], "is_original_packager": [true], "upc": ["0300650795159"], "unii": ["M4I0D6VV5M", "02F3473H9O", "660YQ98I10", "4550K0SC9B", "451W47IQ8X", "1Q73Q2JULR"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1033-2022", "product_description": "BSS Sterile Irrigating Solution (balanced salt solution), 15 mL bottle, Rx only, MFG: Alcon Surgical Inc, NDC 0065-0795-15", "product_quantity": "13 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050779"], "brand_name": ["CEFAZOLIN SODIUM"], "generic_name": ["CEFAZOLIN SODIUM"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-3103", "0264-3105", "0264-3107"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CEFAZOLIN SODIUM"], "rxcui": ["1665050", "1665060", "2630753"], "spl_id": ["fb2f076a-22b3-46e0-86c8-7678e89c9edf"], "spl_set_id": ["17f8f038-c204-4dab-80d7-6f7ac41ddbec"], "package_ndc": ["0264-3103-11", "0264-3105-11", "0264-3107-11"], "is_original_packager": [true], "unii": ["P380M0454Z"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1117-2022", "product_description": "Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3103-11", "product_quantity": "26 cases", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0732-2022", "product_description": "TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy", "product_quantity": "620 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lots: a)746000 BUD: 6/26/2022; b) 751472 BUD: 7/20/2022"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0917-2022", "product_description": "Alpha Lipoic Acid 25 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0076-30", "product_quantity": "3286 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: L24C06, L24B06 BUD: 6/6/2022; B41023-22 BUD: 8/23/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0807-2022", "product_description": "SB-5, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . PGE 50 mcg/mL, 10 mL, Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0024-10.", "product_quantity": "1110 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E48B18 BUD: 5/18/2022, E48D18 BUD; 5/18/2022, H24D31 BUD: 8/31/2022; E48C18 BUD: 5/18/2022", "more_code_info": ""}, {"status": "Completed", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077651"], "brand_name": ["ZONISAMIDE"], "generic_name": ["ZONISAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-128", "68462-129", "68462-130"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZONISAMIDE"], "rxcui": ["314285", "403966", "403967"], "spl_id": ["c00ccc2d-52c6-4a11-a310-d8db25ca3928"], "spl_set_id": ["fe15e56e-8b86-4a65-825c-31d37dd81612"], "package_ndc": ["68462-128-01", "68462-128-05", "68462-129-01", "68462-129-05", "68462-130-01", "68462-130-05"], "is_original_packager": [true], "upc": ["0368462130018", "0368462129012", "0368462128015"], "nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["459384H98V"]}, "product_type": "Drugs", "event_id": "90029", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0792-2022", "product_description": "Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-129-01", "product_quantity": "12,003 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220425", "center_classification_date": "20220427", "report_date": "20220504", "code_info": "Lot #: 29200064, Exp 5/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0809-2022", "product_description": "ST-1, Papaverine 30 mg/mL . Phentolamine 1.5 mg/mL . Alprostadil 50 mcg/ml, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0011-10.", "product_quantity": "525 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: H24F03 BUD: 8/3/2022, H24E03 BUD: 8/3/2022", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0922-2022", "product_description": "Cyanocobalamin 2 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0115-10", "product_quantity": "1282 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: B24115-22 BUD: 8/15/2022; L24001 BUD: 6/1/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020503"], "brand_name": ["ALBUTEROL SULFATE"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-7296"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["2123111"], "spl_id": ["25dfead5-2e15-f328-e063-6294a90ac356"], "spl_set_id": ["f8a2c4b7-a162-48ab-90b0-350e4da25c66"], "package_ndc": ["0781-7296-85"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1024-2022", "product_description": "Albuterol Sulfate Inhalation Aerosol HFA 90 mcg, with Dose Indicator, 200 metered inhalations, Rx only, Distributed by: Sandoz Inc., NDC 0781-7296-85", "product_quantity": "1 aerosol", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0823-2022", "product_description": "Testosterone Cypionate 200 mg/mL (in Grapeseed Oil), Packaged in a) 10 mL Multi-Dose vial, NDC 73198-0054-10; b) 5 mL Multi-Dose vial, NDC 73198-0054-05, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.", "product_quantity": "7161 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: a) D48027 BUD: 4/27/2022,E47017 BUD: 5/17/2022, F42007 BUD: 6/7/2022, F42107 BUD: 6/7/2022, F42207 BUD: 6/7/2022, F48009 BUD: 6/9/2022, F48109 BUD: 6/9/2022, H47003 BUD: 8/3/2022; b) F24024 BUD: 6/24/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89808", "recalling_firm": "Drug Depot, Inc., dba APS Pharmacy", "address_1": "34911 Us Highway 19 N Ste 600", "address_2": "N/A", "postal_code": "34684-1921", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA including Puerto Rico.", "recall_number": "D-0733-2022", "product_description": "TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable, Packaged in a multi dose 10ml vial, Formula ID 115498, APS Pharmacy", "product_quantity": "0", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20220323", "center_classification_date": "20220329", "termination_date": "20231005", "report_date": "20220406", "code_info": "Lot:759312 BUD: 8/30/2022"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1133-2022", "product_description": "Morbillinum, Potency:7C, 8C, 9C, 10C 12C, 13C, 15C, 20C, 21C, 30C, 200 C,Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "72 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot# 20307, 20309", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078245"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-215", "68180-216", "68180-217"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["32db19ef-5d4a-4330-93ec-1a8d595e8f2a"], "spl_set_id": ["ee1eaaf6-050b-48af-942b-5e3451edc164"], "package_ndc": ["68180-215-09", "68180-215-03", "68180-215-01", "68180-215-06", "68180-216-06", "68180-216-09", "68180-216-01", "68180-216-03", "68180-217-06", "68180-217-09", "68180-217-01", "68180-217-03"], "is_original_packager": [true], "upc": ["0368180215066", "0368180217060"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "89916", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide", "recall_number": "D-0843-2022", "product_description": "Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg  a) 30-count bottles (NDC# 68180-216-06)  b) 90-count bottles (NDC# 68180-216-09), Rx Only, Manufactured By: Lupin Limited, Pithampur, India, MFG For: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, USA", "product_quantity": "2,361,924 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220331", "center_classification_date": "20220503", "termination_date": "20230522", "report_date": "20220511", "code_info": "Lot #  H001878 6/30/2022 68180-216-06  H002178 7/31/2022 68180-216-06  H002626 9/30/2022 68180-216-06  H102149 9/30/2023 68180-216-06  H001600 5/31/2022 68180-216-09  H001601 5/1/2022         68180-216-09  H001625 5/31/2022 68180-216-09  H001626 5/31/2022 68180-216-09  H001794 6/30/2022 68180-216-09  H001795 6/30/2022 68180-216-09  H001796 6/30/2022 68180-216-09  H001797 6/30/2022 68180-216-09  H001879 6/30/2022 68180-216-09  H001880 6/30/2022 68180-216-09  H001881 6/30/2022 68180-216-09  H001942 6/30/2022 68180-216-09  H001943 6/30/2022 68180-216-09  H001944 6/30/2022 68180-216-09  H001945 6/30/2022 68180-216-09  H001946 6/30/2022 68180-216-09  H002179 7/31/2022 68180-216-09  H002180 7/31/2022 68180-216-09  H002181 8/31/2022 68180-216-09  H002182 8/31/2022 68180-216-09  H002183 8/31/2022 68180-216-09  H002237 8/31/2022 68180-216-09  H002238 8/31/2022 68180-216-09  H002239 8/31/2022 68180-216-09  H002240 8/31/2022 68180-216-09  H002241 8/31/2022 68180-216-09  H002627 9/30/2022 68180-216-09  H002628 9/30/2022 68180-216-09  H002629 9/30/2022 68180-216-09  H002630 9/30/2022 68180-216-09  H002631 9/30/2022 68180-216-09  H002979 11/30/2022 68180-216-09  H002980 11/30/2022 68180-216-09  H002981 11/30/2022 68180-216-09  H002982 11/30/2022 68180-216-09  H002983 11/30/2022 68180-216-09  H100112 12/31/2022 68180-216-09  H100113 12/31/2022 68180-216-09  H100114 12/31/2022 68180-216-09  H100115 12/31/2022 68180-216-09  H100116 12/31/2022 68180-216-09  H100156 12/31/2022 68180-216-09  H100157 12/31/2022 68180-216-09  H100622 2/28/2023 68180-216-09  H100623 2/28/2023 68180-216-09  H100624 2/28/2023 68180-216-09  H100625 2/28/2023 68180-216-09  H100626 2/28/2023 68180-216-09  H100627 2/28/2023 68180-216-09  H100628 2/28/2023 68180-216-09  H100629 2/28/2023 68180-216-09  H100939 4/30/2023 68180-216-09  H100940 4/30/2023 68180-216-09  H100941 4/30/2023 68180-216-09  H100942 4/30/2023 68180-216-09  H100943 4/30/2023 68180-216-09  H101094 5/31/2023 68180-216-09  H101095 5/31/2023 68180-216-09  H101096 5/31/2023 68180-216-09  H101097 5/31/2023 68180-216-09  H101098 5/31/2023 68180-216-09  H101151 5/31/2023 68180-216-09  H101152 5/31/2023 68180-216-09  H101290 5/31/2023 68180-216-09  H101291 5/31/2023 68180-216-09  H101292 5/31/2023 68180-216-09  H101293 5/31/2023 68180-216-09  H101323 5/31/2023 68180-216-09  H101324 5/31/2023 68180-216-09  H101823 7/31/2023 68180-216-09  H101824 7/31/2023 68180-216-09  H101825 7/31/2023 68180-216-09  H101853 8/31/2023 68180-216-09  H101854 8/31/2023 68180-216-09  H101855 8/31/2023 68180-216-09  H101856 8/31/2023 68180-216-09  H102127 9/30/2023 68180-216-09  H102128 9/30/2023 68180-216-09  H102129 9/30/2023 68180-216-09  H102130 9/30/2023 68180-216-09  H102150 9/30/2023 68180-216-09  H102151 9/30/2023 68180-216-09  H102152 9/30/2023 68180-216-09  H102153 9/30/2023 68180-216-09  H102154 9/30/2023 68180-216-09  H102155 9/30/2023 68180-216-09  H102201 9/30/2023 68180-216-09  H102223 9/30/2023 68180-216-09  H102268 9/30/2023 68180-216-09  H102269 9/30/2023 68180-216-09  H102270 9/30/2023 68180-216-09  H102271 9/30/2023 68180-216-09"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0811-2022", "product_description": "QM-3, Papaverine 30 mg/mL . Phentolamine 3 mg/mL . Alprostadil 150 mcg/mL . Atropine 0.2 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0019-10.", "product_quantity": "1679 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: E42B12 BUD: 5/12/2022, E42C12 BUD: 5/12/2022, E42D12 BUD: 5/12/2022, H24B23 BUD: 8/23/2022, H24C23 BUD: 8/23/2022, H24D23 BUD: 8/23/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90091", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA", "recall_number": "D-0854-2022", "product_description": "Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Fizer Inc, NY, NY  10017, NDC 0009-0068-07.", "product_quantity": "110 bottles", "reason_for_recall": "Failed Dissolution Specifications: low out of specification results for dissolution.", "recall_initiation_date": "20220428", "center_classification_date": "20220506", "termination_date": "20230713", "report_date": "20220518", "code_info": "Lot #: DX7983, exp. date 02/28/2023"}, {"status": "Terminated", "city": "Albuquerque", "state": "NM", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90183", "recalling_firm": "Calvin Scott & Company, Inc.", "address_1": "209 Eubank Blvd Ne", "address_2": "", "postal_code": "87123-2745", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "1 physician in Alpharetta, GA", "recall_number": "D-1123-2022", "product_description": "Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50", "product_quantity": "13 bottles", "reason_for_recall": "Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.", "recall_initiation_date": "20210115", "center_classification_date": "20220609", "termination_date": "20221108", "report_date": "20220601", "code_info": "CSI Lot: CS-20274-005, Exp 5/22", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075682"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-5853", "0904-5854", "0904-5855"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197805", "197806", "197807"], "spl_id": ["9316ff41-1d6d-4538-821c-6835bfce15eb"], "spl_set_id": ["ba86e936-ef72-43e5-aebf-f2c788fe2266"], "package_ndc": ["0904-5853-61", "0904-5853-60", "0904-5853-40", "0904-5854-61", "0904-5854-60", "0904-5854-40", "0904-5855-61", "0904-5855-60", "0904-5855-40"], "original_packager_product_ndc": ["55111-682", "55111-683", "55111-684"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1055-2022", "product_description": "Ibuprofen Tablets USP, 400 mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-5853-61", "product_quantity": "1 carton/100 blisters per carton", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210761"], "brand_name": ["MEDROXYPROGESTERONE ACETATE"], "generic_name": ["MEDROXYPROGESTERONE ACETATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-091"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["MEDROXYPROGESTERONE ACETATE"], "rxcui": ["1000153"], "spl_id": ["10fdc3f5-de88-4bbb-9f3f-c0a0630d0222"], "spl_set_id": ["01e28bef-9758-40cf-a4ff-86ae9f4f5105"], "package_ndc": ["62756-091-40"], "is_original_packager": [true], "unii": ["C2QI4IOI2G"]}, "product_type": "Drugs", "event_id": "90151", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "USA Nationwide", "recall_number": "D-1145-2022", "product_description": "medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 62756-091-40.", "product_quantity": "4625 syringes", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20220506", "center_classification_date": "20220610", "termination_date": "20230814", "report_date": "20220622", "code_info": "Lot #: HAC1951A, Exp 06/2023", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0923-2022", "product_description": "Pyridoxine 100 mg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals,  6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0066-30", "product_quantity": "1306 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: A24018-22 BUD: 7/18/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0799-2022", "product_description": "T-105, Papaverine 30mg/mL . Phentolamine 1mg/ml . PGE 10mcg/ml, , Packaged as a) 10 ml Multi-Dose vial, NDC 73198-0005-10; b) 5 ml Multi-Dose vial,  NDC 73198-0005-05; c) 2.5 ml Multi-Dose vial, NDC 73198-0005-03;  Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835 .", "product_quantity": "6916 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: a) D41412 BUD: 4/22/2022, E41F10 BUD: 5/10/2022, E41G10 BUD: 5/10/2022, F24D21 BUD: 6/21/2022 ; b) D41512 BUD: 4/12/2022; c) F42B21 BUD: 6/21/2022, H42B03 BUD: 8/3/2022, H42C03 BUD: 8/3/2022", "more_code_info": ""}, {"status": "Completed", "city": "Lawrence", "state": "KS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89879", "recalling_firm": "Plastikon Healthcare LLC", "address_1": "3780 Greenway Cir", "address_2": "N/A", "postal_code": "66046-5440", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed in Indiana for further distribution in the USA.", "recall_number": "D-0871-2022", "product_description": "Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone 120mg, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Distributed by Major Pharmaceuticals, Livonia, MI 48152, NDC: 0904-6838-73.", "product_quantity": "106,400 Unit Dose cups", "reason_for_recall": "CGMP Deviations: Failure to properly investigate failed microbial testing.", "recall_initiation_date": "20220324", "center_classification_date": "20220513", "report_date": "20220525", "code_info": "Lot:  20042A, 20043A, 20045A, 20046A, 20047A, EXP May 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90127", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to FL, SC and VA", "recall_number": "D-0887-2022", "product_description": "Losartan HCTZ 100/12.5 mg, 90 count bottles  NDC# 70518-2564-00 Repackaged NDC  Original NDC # 68180-0216-09", "product_quantity": "30 bottles/90 count = 2,700 tablets", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.", "recall_initiation_date": "20220502", "center_classification_date": "20220520", "termination_date": "20220902", "report_date": "20220601", "code_info": "Lot #   B1364261-092721, exp. date 09/30/2022  B1377667-100521, exp. date 10/31/2022  B1412576-102621, exp. date 10/31/2022  B1436925-111321, exp. date 11/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0822-2022", "product_description": "Phenylephrine 1 mg/mL, 5 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0021-05.", "product_quantity": "4521 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lot: H47030 BUD: 8/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "East Hanover", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90176", "recalling_firm": "Novartis Pharmaceuticals Corporation", "address_1": "1 Health Plz", "address_2": "", "postal_code": "07936-1016", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0985-2022", "product_description": "Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.", "product_quantity": "279,179 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications.", "recall_initiation_date": "20220510", "center_classification_date": "20220606", "termination_date": "20240228", "report_date": "20220615", "code_info": "Lot #: a) and b) 19F39, Exp. Date 06/2022; 19P27, Exp. Date 10/2022; 20CD1, Exp. Date 03/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0996-2022", "product_description": "Topex (benzocaine 20%), Topical Anesthetic Gel Strawberry, 1 oz, Rx only, Manufacturer: DS Healthcare, NDC 0699-5116-01", "product_quantity": "24 bottles", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Completed", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA020563"], "brand_name": ["HUMALOG"], "generic_name": ["INSULIN LISPRO"], "manufacturer_name": ["Eli Lilly and Company"], "product_ndc": ["0002-7510", "0002-7533", "0002-8799", "0002-7516", "0002-7714", "0002-8213", "0002-0800", "0002-7712", "0002-8208"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN LISPRO"], "rxcui": ["242120", "865098", "1652239", "1652242", "1652639", "1652640", "1652644", "1652646", "1926331", "1926332", "2621571", "2621572"], "spl_id": ["3d52c48f-89cd-4d3d-8db6-1789e76a1c79"], "spl_set_id": ["c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f"], "package_ndc": ["0002-7510-01", "0002-7510-17", "0002-7510-99", "0002-7533-01", "0002-8799-01", "0002-8799-59", "0002-8799-61", "0002-7516-01", "0002-7516-59", "0002-7516-99", "0002-7714-01", "0002-7714-59", "0002-7714-61", "0002-8213-01", "0002-8213-05", "0002-0800-01", "0002-7712-01", "0002-7712-27", "0002-7712-61", "0002-8208-01", "0002-8208-27"], "is_original_packager": [true], "nui": ["N0000004931", "N0000175453"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["GFX7QIS1II", "059QF0KO0R"]}, "product_type": "Drugs", "event_id": "89976", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NM only", "recall_number": "D-0882-2022", "product_description": "Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59", "product_quantity": "1 box", "reason_for_recall": "TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.", "recall_initiation_date": "20220405", "center_classification_date": "20220519", "report_date": "20220525", "code_info": "Unknown", "more_code_info": ""}, {"status": "Ongoing", "city": "Oshkosh", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90298", "recalling_firm": "A.P. Nonweiler", "address_1": "3321 County Road A", "address_2": "", "postal_code": "54901-1414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in States of WI and VA", "recall_number": "D-1142-2022", "product_description": "Alcohol Antiseptic 80%, Topical Solution, Hand Sanitizer, Non-Sterile Solution, Packaged as (a) 250 U.S. gallons per tote, Product Code 9999D361-250: (b) 1 U.S. gallon, Product Code 9999D361-001: A.P. Nonweiler Co., Inc., 3321 County Road A, Oshkosh, WI 54901.", "product_quantity": "833 gallons", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20220511", "center_classification_date": "20220610", "report_date": "20220622", "code_info": "Lot: 54931, No Expiration date.", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0956-2022", "product_description": "Glycopyrrolate Injection, USP, 0.6 mg/3 mL (0.2 mg/mL), Preservative Free, 3 mL Pre-Filled Syringe, 5 x 3 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-903-03", "product_quantity": "6150 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lot: GL2002A, Exp. 8/13/2022"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019137"], "brand_name": ["BETAMETHASONE DIPROPIONATE"], "generic_name": ["BETAMETHASONE DIPROPIONATE"], "manufacturer_name": ["E. Fougera & Co. a division of Fougera Pharmaceuticals Inc."], "product_ndc": ["0168-0055", "0168-0056", "0168-0057"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["BETAMETHASONE DIPROPIONATE"], "rxcui": ["197405", "238920", "240209"], "spl_id": ["f50b2abb-1a2d-4509-b1fe-617d9a4556a4"], "spl_set_id": ["97dde5f5-a865-4af2-b562-8da72c8475f3"], "package_ndc": ["0168-0055-15", "0168-0055-46", "0168-0056-15", "0168-0056-46", "0168-0057-60"], "is_original_packager": [true], "upc": ["0301680056159", "0301680055466"], "unii": ["826Y60901U"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1028-2022", "product_description": "Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46", "product_quantity": "1 tube", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90151", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "USA Nationwide", "recall_number": "D-1146-2022", "product_description": "medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Manufactured for: Northstart Rx LLC, Memphis, TN,  38141, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India  , NDC 16714-981-01.", "product_quantity": "180813 syringes", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20220506", "center_classification_date": "20220610", "termination_date": "20230814", "report_date": "20220622", "code_info": "Lot: HAC2075A, Exp 06/2023; HAC2076A, Exp 07/2023; HAC2077A, HAC2078A, Exp 08/2023; HAC3803A, Exp 09/2023; HAC0551A, Exp 02/2023; HAC0562A, HAC1183A, Exp 03/2023; HAC1807A, Exp 06/2023; JKX6017A, JKX6018A  Exp 12/2022; HAC0163A, Exp 01/2023; HAC1184A, Exp 04/2023; HAC0162A, Exp 12/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Columbia", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89937", "recalling_firm": "The Ritedose Corporation", "address_1": "1 Technology Cir", "address_2": "", "postal_code": "29203-9591", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0745-2022", "product_description": "23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503B Outsourcing Facility, A Division of the RITEDOSE Corporation, 1 Technology Circle, Columbia, SC 29203, 1-866-994-4670, NDC: 65302-509-30, barcode N (01) 003 65302 50930 0", "product_quantity": "3795 syringes", "reason_for_recall": "Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.", "recall_initiation_date": "20220401", "center_classification_date": "20220405", "termination_date": "20221202", "report_date": "20220413", "code_info": "Lots: 210137-01 BUD: 05/25/2022; 220026-01 BUD: 8/12/2022; 220050-01 BUD: 08/22/2022", "more_code_info": ""}, {"status": "Completed", "city": "Bentonville", "state": "AR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "90359", "recalling_firm": "Walmart Inc", "address_1": "702 Sw 8th St Ms 275", "address_2": "", "postal_code": "72716-6299", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1157-2022", "product_description": "Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800, Mexico, D.F., UPC 7 501031 111190.", "product_quantity": "1308 bottles total", "reason_for_recall": "Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation.", "recall_initiation_date": "20220524", "center_classification_date": "20220624", "report_date": "20220622", "code_info": "Lot: LTARTKNGOMG30720, Exp Diciembre 2026", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA050616"], "brand_name": ["TOBRADEX"], "generic_name": ["TOBRAMYCIN AND DEXAMETHASONE"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "product_ndc": ["0078-0876"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["DEXAMETHASONE", "TOBRAMYCIN"], "rxcui": ["208821", "309682"], "spl_id": ["11f2ad7a-2b97-4316-84b5-49fee866fa81"], "spl_set_id": ["7f310e0e-0d3b-493d-b6c4-238493a2a9b9"], "package_ndc": ["0078-0876-01"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450", "N0000175477", "M0000946"], "pharm_class_epc": ["Corticosteroid [EPC]", "Aminoglycoside Antibacterial [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "pharm_class_cs": ["Aminoglycosides [CS]"], "unii": ["7S5I7G3JQL", "VZ8RRZ51VK"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0995-2022", "product_description": "TobraDex (tobramycin and dexamethasone), Ophthalmic Ointment, 3.5 gm, Rx only, Manufacturer: Novartis, NDC 0078-0876-01", "product_quantity": "3 tubes", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.     The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions.", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1137-2022", "product_description": "Streptococcinum, Potency: 8C, 9C, 30C, 200C, Liquid Pellets, Rx only,  Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "5 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot# 21902, 21927", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076899"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-2725"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198335"], "spl_id": ["b9b2bafa-6f1d-4874-a864-d2878d4c87a2"], "spl_set_id": ["abe0d2d5-4879-4b4e-9b57-47ea83a17ba0"], "package_ndc": ["0904-2725-61"], "original_packager_product_ndc": ["65162-272"], "nui": ["N0000175504", "M0020790", "N0000185504", "N0000175489", "N0000000191", "N0000187062", "N0000187061"], "pharm_class_epc": ["Sulfonamide Antimicrobial [EPC]", "Dihydrofolate Reductase Inhibitor Antibacterial [EPC]"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_moa": ["Cytochrome P450 2C9 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "unii": ["JE42381TNV", "AN164J8Y0X"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1059-2022", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, USP, 800mg/160mg, 100-count unit dose box, Rx only, MFG: Major Pharma, NDC 0904-2725-61", "product_quantity": "32 cartons/100 blister packs per carton", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0933-2022", "product_description": "Lipostat-Plus Methionine 25 mg/mL Inositol 50 mg/mL Choline Chloride 50 mg/mL Cyanocobalamin 1 mg/mL Pyridoxine HCL 175 mcg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals,  6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0047-30.", "product_quantity": "4843 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: A24H26-22, A24G26-22 BUD: 7/26/2022, K24130 BUD: 5/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA204790"], "brand_name": ["TIVICAY"], "generic_name": ["DOLUTEGRAVIR SODIUM"], "manufacturer_name": ["ViiV Healthcare Company"], "product_ndc": ["49702-226", "49702-255", "49702-227", "49702-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOLUTEGRAVIR SODIUM"], "rxcui": ["1433873", "1433879", "1796077", "1796079", "1796081", "1796083", "2374562", "2374566"], "spl_id": ["a9175b83-2200-4bd2-9ee3-52095b5d2657"], "spl_set_id": ["63df5af3-b8ac-4e76-9830-2dbb340af922"], "package_ndc": ["49702-255-37", "49702-226-13", "49702-227-13", "49702-228-13"], "is_original_packager": [true], "upc": ["0349702227132", "0349702226135", "0349702228139"], "unii": ["1Q1V9V5WYQ"]}, "product_type": "Drugs", "event_id": "90166", "recalling_firm": "GlaxoSmithKline LLC", "address_1": "1011 N Arendell Ave", "address_2": "", "postal_code": "27597-2309", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0896-2022", "product_description": "Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.", "product_quantity": "328 bottles", "reason_for_recall": "Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.", "recall_initiation_date": "20220513", "center_classification_date": "20220525", "termination_date": "20230817", "report_date": "20220601", "code_info": "Lot: 2A9E, Exp 1/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0817-2022", "product_description": "PGE-1, Alprostadil 40 mcg/mL, 10ml Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0028-10.", "product_quantity": "821 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: I24028 BUD: 9/28/2022,F47C30 BUD: 6/30/2022, F47B30 BUD: 6/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1063-2022", "product_description": "MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01", "product_quantity": "363 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richardson", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89954", "recalling_firm": "North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding", "address_1": "1736 N Greenville Ave", "address_2": "", "postal_code": "75081-1808", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States", "recall_number": "D-0780-2022", "product_description": "PT-141 (Bremelanotide Acetate) 10 mg/mL (2 mL) Injection, 2mL vials, Rx Only, Farmakeio 1736 N Greenville Ave Richardson, TX 75081", "product_quantity": "43 vials", "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.", "recall_initiation_date": "20220405", "center_classification_date": "20220421", "termination_date": "20231005", "report_date": "20220427", "code_info": "Lot #: 32616 BUD: 4/4/2022; 34527 BUD: 5/24/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Cedar Rapids", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90197", "recalling_firm": "Eco Lips, Inc", "address_1": "6000 Huntington Ct Ne", "address_2": "", "postal_code": "52402-1268", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "CA", "recall_number": "D-0890-2022", "product_description": "Higher Education Make Out Ready Vegan Lip Balm, SPF 15, Net Wt. 0.15 oz (4.25 g) per tube, Active Ingredients: Oxtinoxate (7.5%), Oxybenzone (3%); Distributed by: Higher Education Skincare, 1.833.251.0388", "product_quantity": "17,000 units", "reason_for_recall": "Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product therein is made with Octinoxate 7.5%, Octisalate 5%, Octocrylene 5%, and Avobenzone 3%.", "recall_initiation_date": "20220429", "center_classification_date": "20220523", "termination_date": "20220825", "report_date": "20220601", "code_info": "Lot 93400-21200", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201720"], "brand_name": ["TESTOSTERONE CYPIONATE"], "generic_name": ["TESTOSTERONE CYPIONATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-015", "62756-017", "62756-016"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["TESTOSTERONE CYPIONATE"], "rxcui": ["835829", "835840", "2047882"], "spl_id": ["bf24bb84-d12f-44e7-98bd-46f3aa792bcc"], "spl_set_id": ["3653a602-4551-4e6c-84a7-31861f5dc482"], "package_ndc": ["62756-017-40", "62756-015-40", "62756-016-40"], "is_original_packager": [true], "upc": ["0362756017405", "0362756015401", "0362756016408"], "unii": ["M0XW1UBI14"]}, "product_type": "Drugs", "event_id": "90391", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1154-2022", "product_description": "Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-015-40.", "product_quantity": "47,500 vials", "reason_for_recall": "Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion", "recall_initiation_date": "20220610", "center_classification_date": "20220622", "termination_date": "20230725", "report_date": "20220629", "code_info": "Lot: HAC3427A,  EXP Date: 08/2023", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0929-2022", "product_description": "Formula F9 Papaverine 0.9 mg/mL Phentolamine 0.1 mg/mL PGE 20 mcg/mL Atropine 0.01 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0004-10", "product_quantity": "205 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: B24G02-22 BUD: 2/2/2023", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0900-2022", "product_description": "SB-5 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 50 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0024-10", "product_quantity": "75 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: B24D02-22 BUD: 02/02/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091269"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Dr.Reddy's Laboratories Ltd."], "product_ndc": ["55111-398", "55111-399"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["311277", "596843"], "spl_id": ["c8eb1d41-1fd2-7c06-486c-e6abf08faa6d"], "spl_set_id": ["82174fcc-1b0f-2068-7fc4-db335b43b5e2"], "package_ndc": ["55111-398-30", "55111-398-60", "55111-398-90", "55111-398-01", "55111-398-05", "55111-398-79", "55111-399-30", "55111-399-60", "55111-399-90", "55111-399-01", "55111-399-05", "55111-399-79"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "89871", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0738-2022", "product_description": "Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India, NDC 55111-399-90.", "product_quantity": "7,703 bottles", "reason_for_recall": "Failed Dissolution Specifications; during long term stability testing.", "recall_initiation_date": "20220323", "center_classification_date": "20220331", "termination_date": "20240202", "report_date": "20220406", "code_info": "Lot# C2102911, Exp. 12/2023"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0936-2022", "product_description": "Methylcobalamin 5 mg/mL, Packaged as a) Multi-Dose 10mL vial, NDC 73198-0051-10; b) Multi-Dose 30mL vial, NDC 73198-0051-30, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835", "product_quantity": "12800 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: L24122, L24C22, L24B22 BUD: 6/22/2022,  A24124-22 BUD: 7/24/2022, A24225-22 BUD: 7/25/2022, A24026-22 BUD: 7/26/2022, A24027-22 BUD: 7/27/2022, A24C31-22, A24B31-22 BUD: 7/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1042-2022", "product_description": "Olanzapine Orally Disintegrating Tablets, USP 10 mg, 30-count box unit dose tablets (3 blister cards each containing 10 tablets), Rx only, MFG: PAR PHARMA, NDC 49884-321-55", "product_quantity": "30 cartons/3 blister packs per carton", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078866"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-736", "47335-737", "47335-738"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993503", "993518", "993536"], "spl_id": ["b8e6ae63-c5d7-4481-b7b0-17e135670515"], "spl_set_id": ["29848192-7de3-4c0d-a822-1268dcf128b0"], "package_ndc": ["47335-736-86", "47335-736-88", "47335-736-08", "47335-736-13", "47335-737-86", "47335-737-88", "47335-737-08", "47335-737-13", "47335-738-86", "47335-738-88", "47335-738-08", "47335-738-13"], "is_original_packager": [true], "upc": ["0347335738865", "0347335737868"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "90088", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0858-2022", "product_description": "buPROPion Hydrochloride Extended-Release Tablet, USP (SR), 200 mg, 60-count bottle, Rx only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-738-86", "product_quantity": "744 bottles", "reason_for_recall": "Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.", "recall_initiation_date": "20220429", "center_classification_date": "20220510", "termination_date": "20230925", "report_date": "20220518", "code_info": "Lot #: HAC2237A, exp. date 05/2023"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019627"], "brand_name": ["DIPRIVAN"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-269"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808219", "1808222", "1808223", "1808224", "1808225", "1808234", "1808235"], "spl_id": ["fcc6b79c-5aa5-4c9f-8f58-fb0a1eeaceec"], "spl_set_id": ["ee0c3437-614d-4631-a061-257f5f60c70b"], "package_ndc": ["63323-269-30", "63323-269-50", "63323-269-35", "63323-269-65", "63323-269-22", "63323-269-29", "63323-269-01", "63323-269-10"], "is_original_packager": [true], "upc": ["0363323269302", "0363323269357", "0363323269012", "0363323269227"], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1116-2022", "product_description": "Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29", "product_quantity": "46 cartons", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0924-2022", "product_description": "Dexpanthenol 250 mg/mL Multi-Dose 30 mL Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0070-30", "product_quantity": "1296 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lot: L24016 BUD: 6/16/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0816-2022", "product_description": "FA, Papaverine 20 mg/mL . Phentolamine 2 mg/mL . Alprostadil 20 mcg/mL . Atropine 0.2 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0006-10.", "product_quantity": "2887 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: F41414 BUD: 6/14/2022, F41C14 BUD: 6/14/2022, I24E28 BUD: 9/28/2022, I24F28 BUD: 9/28/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021730"], "brand_name": ["LEVALBUTEROL TARTRATE HFA INHALATION"], "generic_name": ["LEVALBUTEROL TARTRATE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2927"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVALBUTEROL TARTRATE"], "rxcui": ["745791"], "spl_id": ["f9039b6c-2ae3-416b-bc2a-ab6e06e830bf"], "spl_set_id": ["ac85703a-17a2-4f0b-87f4-78f1756d2f85"], "package_ndc": ["0591-2927-54"], "is_original_packager": [true], "unii": ["ADS4I3E22M"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1067-2022", "product_description": "Levalbuterol Tartrate HFA Inhalation Aerosol, 45 mcg/actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 0591-2927-54", "product_quantity": "2 inhalers", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0958-2022", "product_description": "Hydromorphone HCl Injection, USP, 6 mg/30 mL (0.2 mg/mL), 30 mL Pre-Filled Syringe, 5 x 30 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-529-30", "product_quantity": "6210 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lot: HH2008A, Exp. 9/5/2022"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1130-2022", "product_description": "Diphtherinum, Potency: 14C, 30C, 200C, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411,", "product_quantity": "7 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot # 20332, 20333", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA011757"], "brand_name": ["DEPO-MEDROL"], "generic_name": ["METHYLPREDNISOLONE ACETATE"], "manufacturer_name": ["Pharmacia & Upjohn Company LLC"], "product_ndc": ["0009-3073", "0009-3475"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "SOFT TISSUE"], "substance_name": ["METHYLPREDNISOLONE ACETATE"], "rxcui": ["1743779", "1743781", "1743855", "1743856"], "spl_id": ["befd723e-d1e2-41b9-83f1-17bca0c2a941"], "spl_set_id": ["9a7b3837-e038-48bf-97e9-78ad463760dc"], "package_ndc": ["0009-3073-01", "0009-3073-03", "0009-3475-01", "0009-3475-03"], "is_original_packager": [true], "upc": ["0300093073036"], "unii": ["43502P7F0P"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1097-2022", "product_description": "Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC# 0009-3475-01), b) 25-count box (NDC 0009-3475-03), Rx only, MFG: Pfizer", "product_quantity": "177 cartons", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125248"], "brand_name": ["RECOTHROM"], "generic_name": ["THROMBIN TOPICAL RECOMBINANT"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0322", "0338-0326", "0338-0330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["1367418", "1367420"], "spl_id": ["f37c2fff-8ada-424a-af4b-dfd4c483c694"], "spl_set_id": ["54885644-e51e-4263-aadb-366abaeb56a3"], "package_ndc": ["0338-0322-01", "0338-0324-01", "0338-0326-01", "0338-0328-01", "0338-0330-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1082-2022", "product_description": "Recothrom Thrombin Topical (Recombinant), 5,000 units, packaged in a box containing a 5000-unit vial of RECOTHROM with a 5-mL prefilled diluent syringe (containing sterile 0.9% sodium chloride, USP), a sterile needle-free transfer device, a 5-mL sterile empty syringe, and a pre-printed label, Rx only, MFG: Baxter, NDC# 0338-0322-01", "product_quantity": "110 cartons/5000 units each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}]